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Abstract Studies suggest that placental nutrient supply adapts according to fetal demands.
However, signaling events underlying placental adaptations remain unknown. Here we demonstrate
that phosphoinositide 3-kinase p110a in the fetus and the trophoblast interplay to regulate
placental nutrient supply and fetal growth. Complete loss of fetal p110a caused embryonic death,
whilst heterozygous loss resulted in fetal growth restriction and impaired placental formation and
nutrient transport. Loss of trophoblast p110a resulted in viable fetuses, abnormal placental
development and a failure of the placenta to transport sufficient nutrients to match fetal demands
for growth. Using RNA-seq we identified genes downstream of p110a in the trophoblast that are
important in adapting placental phenotype. Using CRISPR/Cas9 we showed loss of p110a
differentially affects gene expression in trophoblast and embryonic stem cells. Our findings reveal
important, but distinct roles for p110a in the different compartments of the conceptus, which
control fetal resource acquisition and growth.
DOI: https://doi.org/10.7554/eLife.45282.001
Introduction
Intrauterine growth is dictated by the genetically-determined fetal drive for growth and the supply
of nutrients and oxygen to the fetus. In turn, fetal substrate supply depends on the functional capac-
ity of the placenta to transfer nutrients and oxygen from the mother to the fetus. Insufficient fetal
substrate supply prevents the fetus from achieving its genetic growth potential and leads to intra-
uterine growth restriction, which affects up to 10% of the population and is associated with perinatal
morbidity and mortality (Baschat et al., 2007; Baschat and Hecher, 2004). Studies have shown that
the transport capacity of the placenta is diminished in human pregnancies associated with fetal
growth restriction (Glazier et al., 1997; Jansson and Powell, 2006), suggesting that placental insuf-
ficiency may be the underlying cause of a fetus failing to achieve its genetic growth potential. How-
ever, there is also evidence that placental transport capacity may adapt to maintain the supply of
resources appropriate for the growth potential of the fetus (Sandovici et al., 2012; Sferruzzi-
Perri and Camm, 2016). For instance, the placental capacity to supply resources to the fetus is
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higher in the lightest compared to heaviest placentas, supporting babies within the normal birth
weight range (Godfrey et al., 1998). Placental supply capacity is also increased in newborns show-
ing some protection to the growth-restricting effects of altitude-induced hypoxia (Espinoza et al.,
2001; Jackson et al., 1988; Moore et al., 2001). Studies in mice have also shown that the placenta
can adaptively up-regulate its transport function when the fetal demand for resources exceeds the
supply capacity of the placenta, including following reduced expression of nutrient transporter or
growth-regulatory genes, in small placentas within litters, and when the maternal provision of sub-
strates is suboptimal (Coan et al., 2008; Constância et al., 2005; Dilworth et al., 2010;
Higgins et al., 2016; Sferruzzi-Perri et al., 2011; Sferruzzi-Perri et al., 2013b; Vaughan et al.,
2013; Wyrwoll et al., 2009). Taken together, these observations suggest that the placenta may
adopt compensatory mechanisms to help meet the fetal genetic drive for growth, and that perhaps
in severe cases of fetal growth restriction such adaptive attempts fail to occur or are insufficient. The
signaling events which underlie placental adaptations, however, remain to be elucidated.
The phosphoinositide 3-kinases (PI3Ks) are a highly conserved family of enzymes, which are
thought to have evolved to regulate growth in relation to nutrient supply (Engelman et al., 2006;
Kriplani et al., 2015). In response to receptor activation, they generate lipid second messengers to
initiate signaling cascades, which control important physiological processes such as cellular prolifera-
tion, metabolism, survival, polarity and membrane trafficking (Vanhaesebroeck et al., 2010). PI3Ks
can be grouped into three major classes (I, II and III), on the basis of their substrate preference and
sequence similarity. In mammals, Class I PI3Ks can be further subdivided according to the receptors
to which they are coupled to. Class IA PI3Ks have received the most attention to date and they sig-
nal downstream of growth factor receptor tyrosine kinases (Jean and Kiger, 2014). In adult mamma-
lian tissues, the ubiquitously expressed, Class IA isoform p110a plays a key role in mediating the
growth and metabolic effects of insulin and insulin-like growth factors (IGFs) (Foukas et al., 2006;
Knight et al., 2006; Sopasakis et al., 2010), which are major growth factors that also operate dur-
ing feto-placental development (Sferruzzi-Perri et al., 2017; Sferruzzi-Perri et al., 2013a). Studies
in mice show that changes in the PI3K pathway, particularly downstream of p110a are observed in
placentas showing adaptive up-regulation of substrate supply to the fetus in pregnancies challenged
with poor maternal environments and genetically-induced placental growth restriction
(Higgins et al., 2016; Sferruzzi-Perri et al., 2011; Sferruzzi-Perri et al., 2013b). These observations
indicate that p110a may be a part of a critical signaling cascade that integrates various environmen-
tal signals involved in adapting placental resource allocation to fetal growth.
Studies in mice have indicated that homozygous p110a deficiency, either by the complete loss of
Pik3ca gene or by a mutation in Pik3ca which renders the p110a inactive (kinase dead mutation;
p110aD933A/D933A; a/a), results in embryonic death between gestation day 9.5 and 11.5 (Bi et al.,
1999; Foukas et al., 2006; Graupera et al., 2008). When p110a activity is reduced by half, in mice
carrying one copy of the kinase-dead mutation (p110aD933A/+; a/+), fetuses are viable, but weigh
10–15% less than their wildtype littermates in late gestation (Foukas et al., 2006; Sferruzzi-
Perri et al., 2016). Placental weight is also reduced in association with defects in the development
of the labyrinthine transport region in a/+mutants (Sferruzzi-Perri et al., 2016). However, the
capacity of the placenta to transfer maternal glucose and amino acid (via System A) to the fetus per
unit surface area is increased in a/+mutants near term (Sferruzzi-Perri et al., 2016). This suggests
adaptation of placental supply capacity with p110a deficiency. In the a/+mutant the whole concep-
tus is heterozygous for the p110a mutation (Sferruzzi-Perri et al., 2016) and the contribution of the
fetal versus the trophoblast cell lineages in driving changes in placental development and adaptive
responses cannot be discerned. This study therefore, sought to answer the following questions: 1)
what effect does fetal versus trophoblast p110a deficiency have on placental phenotype and
resource allocation to fetal growth? 2) does adaptive upregulation of placental transport depend on
p110a signaling in fetal or trophoblast lineages? and 3) which genes downstream of p110a in the
trophoblast compartment of the conceptus are implicated in adapting placental phenotype to sup-
port fetal growth in late mouse pregnancy? To achieve this, we selectively manipulated the expres-
sion of the p110a gene (Pik3ca) in the trophoblast and/or fetal cell lineages and assessed the impact
on placental morphology, transport and transcriptome in relation to fetal growth.
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Results
Fetal and trophoblast p110a interplay to regulate growth of the
conceptus
We found PI3K p110a was highly expressed in the placental transport labyrinthine zone and the
endocrine junctional zone of the mouse placenta (Figure 1—figure supplement 1). We then halved
the p110a expression in either the trophoblast or the fetal (epiblast-derived) lineages of the concep-
tus by crossing mice in which exons 18–19 of the Pik3ca gene were flanked by LoxP sites
(Graupera et al., 2008), to Cyp19Cre (Wenzel and Leone, 2007) and Meox2Cre (Tallquist and Sor-
iano, 2000) mice, respectively, referred to as Het-P and Het-F throughout. These Cre lines are active
in opposite compartments of the conceptus; for Het-P the Cyp19Cre targets expression in the tro-
phoblast lineages of the placenta but not fetus, labyrinthine fetal capillaries or mesenchyme in the
chorion (Figure 1A and C). In contrast, in Het-F the Meox2Cre deletes p110a expression in the fetus
and placental labyrinthine fetal capillaries and chorionic mesenchyme but not trophoblast (Figure 1B
and C) (further information regarding the genetic crosses can be found in Figure 1—source data 1).
We then compared the fetal and placental growth phenotype of the conditional Het-P and Het-F
on day 19 of pregnancy (term ~20 days) to conceptuses with global heterozygous p110a deficiency
achieved using the ubiquitous expressing CMVCre line (Schwenk et al., 1995) (termed Het-U,
Figure 1C). We found that compared to their wild-type (WT) littermates, there was no effect of het-
erozygous deficiency of p110a in the trophoblast on fetal or placental weight in Het-P mutants
(Figure 2A). However, fetal and placental weights were 10–15% lower for Het-F and Het-U concep-
tuses (Figure 2B and C). The findings in Het-F and Het-U mutants are consistent with the prolifera-
tion defects observed in embryos with a deficiency in p110a (Bi et al., 1999; Foukas et al., 2006)
and reveal for the first time that p110a in the embryo is important for determining the size of the
placenta.
Although fetal and not trophoblast p110a deficiency reduced conceptus weight, both affected
the structure of the placenta (Figure 3A–C). In the labyrinthine region of Het-P conceptuses, the vol-
ume of maternal blood spaces, fetal capillaries and surface area were reduced though trophoblast
increased compared to their WT controls (Figure 3A). In Het-F conceptuses, the labyrinthine zone,
fetal capillaries and trophoblast volume were decreased versus WT littermates (Figure 3B). In the
ubiquitous p110a heterozygote (Het-U), the volume of the labyrinthine zone, fetal capillaries and tro-
phoblast were reduced, surface area decreased and barrier to diffusion was greater, relative to WT
littermates (Figure 3C). Reassuringly, the same defects in Het-U placental structure were previously
observed for a/+mutants near term (Sferruzzi-Perri et al., 2016). The volume of the endocrine junc-
tional zone in Het-P, Het-F or Het-U placentas was not significantly altered when compared to the
respective WT controls (Figure 3—figure supplement 1). Taken together, these findings indicate
that p110a in the fetal and trophoblast lineages of the conceptus interplay to regulate the develop-
ment of the transport region in the placenta.
Fetal and trophoblast p110a both regulate placental resource
allocation to fetal growth
To assess whether morphological alterations in the placenta affect placental resource allocation to
the fetus in Het-F, Het-U and Het-P, we measured the uni-directional maternal-fetal transfer of the
non-metabolisable analogs of glucose (3H-methyl-D glucose; MeG) and a neutral amino acid (14C-
methyl amino-isobutyric acid; MeAIB) on day 19 of pregnancy. We assessed fetal counts in relation
to the estimated surface area for transport or to fetal weight, which respectively provided us with
indices of the placental capacity for nutrient transfer and fetal growth relative to supply. We found
that in compensation for the impaired labyrinthine development, Het-P and Het-U placentas trans-
ferred more MeG and MeAIB and Het-F more MeAIB per unit surface area compared to their
respective WT littermates (Figure 4A–C). In agreement with these findings, mutant fetuses received
either normal (MeG in all mutants and MeAIB in Het-P and Het-F) or increased amount of solutes
(MeAIB in Het-U) for their size (Figure 4D–F). Moreover, the total fetal accumulation of these solutes
was the same in the mutant and WT fetuses (Figure 4—figure supplement 1). These data suggest
an adaptive response of both facilitated (MeG) and active (MeAIB) transport functions in placentas
that are morphologically compromised by a lack of fetal or trophoblast p110a.
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Figure 1. Successful modulation of p110a expression in the conceptus. (A–B) Validation that Cyp19Cre (A) and Meox2Cre (B) are active in opposite
compartments in the conceptus by crossing lines to the tdTomato reporter and assessing placentas and fetuses on day 16 of pregnancy. Boxes in A
and B are shown in high magnification in i and ii, respectively. Scale bar for fetuses and placentas in A and B = 2 mm and 1 mm, in i and ii = 200 mm,
and in iii and iv = 20 mm, respectively. (C) qRT-PCR for Pik3ca gene normalized to Gapdh in whole homogenates of fetus and placenta of Het-P, Het-F,
Het-U and Hom-P mutants on day 19 of pregnancy, expressed as a ratio of their respective wild-type control (WT, denoted as a dotted line). Gapdh
expression was not affected by genotype. *p<0.05, **p<0.01, and ***p<0.001 versus WT, unpaired t test. n  4 per genotype. Het-F = heterozygous
deficiency in the fetus, Het-P = heterozygous deficiency in the placenta, Het-U = heterozygous deficiency in the fetus and placenta, Hom-
P = heterozygous deficiency in the fetus and homozygous deficiency in the placenta, Jz = Junctional zone, Lz = Labyrinth zone, T = Trophoblast.
DOI: https://doi.org/10.7554/eLife.45282.002
The following source data and figure supplement are available for figure 1:
Source data 1. Summary of the mouse strains and experimental crosses used in the study.
DOI: https://doi.org/10.7554/eLife.45282.004
Figure supplement 1. The expression of p110a protein by the mouse placenta on day 19 of pregnancy.
DOI: https://doi.org/10.7554/eLife.45282.003
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Fetal p110a is essential for embryonic development and trophoblast
p110a is critical for its ability to up-regulate amino acid transport to
match fetal demands for growth
We wanted to know more about the regulation of placental resource allocation to the developing
fetus when there is a loss of fetal and trophoblast p110a. In particular, we wondered whether adap-
tation of placental transport function would still occur in heterozygous mutants (Het-U) if the tropho-
blast or fetal lineages were completely deficient in p110a. To do this, we selectively deleted the
Figure 2. Feto-placental growth is regulated by fetal but not trophoblast p110a. (A) Het-P (n = 15) compared to
WT (n = 26) (B), Het-F (n = 30) compared to WT (n = 21) and (C) Het-U (n = 18) compared to WT (n = 26) on day 19
of pregnancy. *p<0.05 and ***p<0.001 versus WT, unpaired t test. Note, there was no significant difference in fetal
weight between Het-F and WT when data were analyzed by paired t test. Data from individual conceptuses are
shown and the mean is denoted as a horizontal line with SEM.
DOI: https://doi.org/10.7554/eLife.45282.006
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remaining p110a from the trophoblast or the fetal compartment of Het-U mice, using Cyp19Cre and
Meox2Cre, respectively (termed Hom-P and Hom-F, respectively). We found that deleting the
remaining p110a from the fetal lineages was lethal between days 11 and 12 of pregnancy (Table 1).
In contrast to the lethality of Hom-F embryos, we found viable Hom-P fetuses in late gestation
(Figure 1C and Table 1—source data 1). The timing of Hom-F lethality was identical to mutants
with constitutive homozygous deficiency of p110a (a/a; Foukas et al., 2006) and is consistent with
the role of p110a in early murine embryonic development (Xu et al., 2009). Taken together, these
findings highlight that p110a in the fetal, but not the trophoblast compartment of the conceptus, is
obligatory for prenatal development.
When comparing the growth of the Hom-P conceptuses to the control Het-U littermates, we
found that fetal growth was restricted by a further 8% on day 19 of pregnancy (Table 2). However,
despite the reduction in fetal growth, there was no difference in placental weight and labyrinthine
morphology in Hom-P versus Het-U (Table 2). These observations suggest that the more severe
Figure 3. Placental morphology is regulated by both fetal and trophoblast p110a. (A) Het-P, (B) Het-F and (C) Het-U placental morphology on day 19
of pregnancy as determined by stereology. *p<0.05, **p<0.01, and ***p<0.001 versus WT, unpaired t test. Data presented as means ± SEM. Scale bar
for hematoxylin and eosin-stained placental cross-sections is 500 mm. 6–10 placentas were assessed for each genotype for labyrinthine zone (Lz) volume
and 4–5 analysed for Lz morphology.
DOI: https://doi.org/10.7554/eLife.45282.008
The following figure supplement is available for figure 3:
Figure supplement 1. Junctional zone volume is not modified by fetal and/or trophoblast loss of p110a.
DOI: https://doi.org/10.7554/eLife.45282.009
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reduction in fetal growth in Hom-P (relative to Het-U), was not caused by additional defects in the
formation of the placental exchange region due to a complete loss of p110a in the trophoblast.
We wondered whether the greater reduction in fetal growth may have been caused by a defect
in placental transport function (a failure of the placenta to adapt its transfer capacity) in the Hom-P
versus the Het-U mutants. We found that Hom-P placentas transferred 30% less amino acid (MeAIB)
for the surface area available than Het-U littermates (Figure 5A). Furthermore, Hom-P fetuses
received less MeAIB solute for their size, as well as overall (Figure 5—figure supplement 1). As the
Figure 4. Placental nutrient transfer is adaptively increased in response to fetal and/or trophoblast loss of p110a.
(A–F) The capacity of the placenta to transport 3H-methyl-D glucose (MeG) and 14C-amino isobutyric acid (MeAIB)
relative to surface area available or to fetal weight (D–F) on day 19 of pregnancy for Het-P (n = 15) (A, D), Het-F
(n = 24) (B, E) and Het-U (n = 16) (C, F), expressed as a ratio of their respective WT control values (denoted as a
dotted line, n = 21, 18 and 21, respectively). DPM = disintegrations per minute. *p<0.05 and ***p<0.001 versus
WT, unpaired t test. Data presented as means ± SEM.
DOI: https://doi.org/10.7554/eLife.45282.010
The following figure supplement is available for figure 4:
Figure supplement 1. Total solute accumulation in response to fetal and/or trophoblast loss of p110a.
DOI: https://doi.org/10.7554/eLife.45282.011
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Het-U placenta up-regulated its transport capacity (Figure 4C), this suggests that the greater reduc-
tion in fetal growth was due to an inability of the Hom-P placenta to adaptively increase amino acid
transfer to the fetus. Placental glucose transfer capacity however, was not affected by a lack of pla-
cental p110a; transfer of MeG by the Hom-P placenta was equal to Het-U (Figure 5—figure supple-
ment 1). Data on feto-placental growth and placental transfer in Hom-P compared to wild-type and
Het-P, which in contrast, retain p110a in fetus, are shown in Table 2—source data 1 and Figure 5—
source data 1. Collectively, our data suggest that the demand signals of the compromised feto-pla-
cental unit for more amino acids operate via p110a in the trophoblast.
Table 1. Deleting the remaining p110a from fetal compartment of the conceptus results in fetal
lethality in Hom-F mutants between days 11 and 12 of pregnancy.
Frequency of viable fetuses in a litter per gestational age are displayed, with the number of litters in
parentheses.
WT Het-F Het-U Hom-F
D10 (5) 23% 26% 34% 17%
D11 (6) 35% 23% 29% 13%
D12 (2) 50% 25% 25% 0%
D13 (3) 39% 33% 28% 0%
DOI: https://doi.org/10.7554/eLife.45282.012
The following source data is available for Table 1:
Source data 1. Deleting the remaining p110a from the trophoblast in Hom-P does not affect fetal viability at day
19 of pregnancy.
Frequency of viable fetuses in a litter are displayed, with data from n = 15 litters. Offspring genotypes were deter-
mined by conventional PCR, and in the case of Cyp19Cre mutants, additionally by qRT-PCR to identify those with
a sufficient level of Pik3ca deletion (frequency is in parentheses). When the cut off for Pik3ca deletion in the pla-
centa using qRT-PCR was applied (<65% for Het-P and <30% for Hom-P), the frequency of Cyp19Cre mutants
was ~50% less.
DOI: https://doi.org/10.7554/eLife.45282.005
Table 2. Deleting the remaining p110a from the trophoblast reduces fetal weight but does not alter
placental growth on day 19 of pregnancy, in Hom-P relative to Het-U controls.
Conceptus weights are from n  18, Lz and Jz volume from n  6 and Lz morphology from n  4 per
genotype. Data are presented as means ± SEM. * versus Het-U, p<0.05, unpaired t test.
Het-U Hom-P
Fetus (mg) 1075 ± 31 994 ± 22*
Placenta (mg) 84 ± 3 89 ± 3
Labyrinthine zone (mm3) 38 ± 3 36 ± 2
Junctional zone (mm3) 31 ± 3 30 ± 2
Maternal blood spaces (mm3) 13 ± 3 11 ± 1
Trophoblast (mm3) 20 ± 1 22 ± 2
Fetal capillaries (mm3) 3 ± 1 4 ± 1
Barrier thickness (mm) 4.0 ± 0.2 3.9 ± 0.1
Surface area (mm2) 11 ± 1 10 ± 1
DOI: https://doi.org/10.7554/eLife.45282.013
The following source data is available for Table 2:
Source data 1. The effect of deleting the remaining p110a from the trophoblast in Hom-P on feto-placental
growth relative to WT and Het-P.
Hom-P * versus WT or † versus Het-P. *p<0.05 and ***p<0.001, †p<0.05 and †††p<0.001, unpaired t test. Concep-
tus weights are from n  15, Lz and Jz volume from n  6 and Lz morphology from n  4 per genotype on day 19
of pregnancy. Data are presented as means ± SEM.
DOI: https://doi.org/10.7554/eLife.45282.007
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Several genes downstream of p110a in the trophoblast are implicated
in changes in placental phenotype to support the growing fetus
To identify genes responsible for the phenotypic differences observed between Het-U and Hom-P
placentas at day 19 of pregnancy we compared their transcriptome using RNA-seq. We identified 97
differentially expressed genes, with 61 up- and 36 down-regulated in Hom-P versus Het-U placenta
(Figure 6—source data 1). As expected, the FPKM (fragments per kilobase of transcript per million
mapped reads) for the floxed exons, 18–19 of Pik3ca (Graupera et al., 2008) was diminished for
Hom-P versus Het-U (Figure 6—figure supplement 1). Using DAVID functional annotation followed
by REViGO filtering we found that genes that were down-regulated in Hom-P compared with Het-U
placentas have been implicated in cytolysis and cell death, proteolysis, regulation of immune effector
processes, whilst those that were up-regulated have proposed roles in cellular hormone metabolic
processes (Figure 6—figure supplement 2). We confirmed using qRT-PCR the differential expres-
sion of several granzyme encoding genes, which are implicated in apoptosis (Gzmc, Gzmf, Gzme,
Gzmd, Gzmb and Gzmg) (Figure 6—source data 1). Granzymes, as well as perforin-1 (which was
also differentially expressed in the Hom-P versus Het-U placenta; Figure 6—source data 1) are
enriched in uterine natural killer cells. However, we found no significant difference in uterine natural
killer cell abundance between Hom-P and Het-U placentas (Figure 6—figure supplement 3). More-
over, paradoxically, we found increased levels of apoptosis in the junctional zone of the Hom-P rela-
tive to the Het-U placenta (Figure 6B and C). Inspecting the list of genes from the RNA-seq dataset
revealed that expression of the main glucose and System A amino acid transporters (Slc2a, Slc38a)
and their proposed regulators (Mtor, Tbc1d4) (Mı̂inea et al., 2005; Rosario et al., 2013) was not dif-
ferent between Hom-P and Het-U placentas. However, genes involved in water and oxygen trans-
port (eg. Aqp1, Aqp5, Hba-a2) were altered (Figure 6—source data 1), suggesting that other
transport capabilities of the placenta may be altered and contribute to the greater fetal growth
restriction observed in the Hom-P versus Het-U. Other differentially expressed genes that were not
featured in the pathway analysis have been implicated in regulating placental physiology (eg, Cdx2,
Figure 5. Retaining trophoblast p110a is critical for the ability of the placenta to increase amino acid transport.
MeG and MeAIB transport relative to surface area available (A) or to fetal weight (B) on day 19 of pregnancy in
Hom-P (n = 16), expressed as a ratio of Het-U control values (denoted as a dotted line, n = 16).
DPM = disintegrations per minute. *p<0.05 versus Het-U, unpaired t test.
DOI: https://doi.org/10.7554/eLife.45282.014
The following source data and figure supplement are available for figure 5:
Source data 1. The effect of deleting the remaining p110a from trophoblast in Hom-P on placental transport
capacity relative to WT and Het-P.
DOI: https://doi.org/10.7554/eLife.45282.016
Figure supplement 1. Total solute accumulation in Het-U versus Hom-P.
DOI: https://doi.org/10.7554/eLife.45282.015
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Cited2, Prl5a1, Prl7c1, Psg19 and Psg22) and pregnancy outcome (eg, Fgl2, Acta2, Ngf and Nov/
Ccn3) (Figure 6—source data 1).
We next identified significant enrichment of binding sites for four transcription factors (STAT1,
ARNT2, HMGA1 and MITF) at the promoters of genes differentially expressed between Hom-P and
Het-U placenta (Figure 6D and E). The mRNA expression of the transcription factors were not
altered in the Hom-P versus Het-U placenta (Figure 6—source data 1), although previous work has
shown that their activity is modified by PI3K signaling (Mounayar et al., 2015; Sheu et al., 2017;
Figure 6. Genes downstream of p110a in the trophoblast implicated in changes in placental phenotype on day 19 of pregnancy. (A) Top-scoring
biological processes enriched in Hom-P (n = 4) versus Het-U (n = 5) placentas on day 19 determined by RNA-seq (see also Figure 6—source data 1).
GO terms enriched in up-regulated genes shown in red and those down-regulated in green. Three genes with the highest fold expression changes are
indicated in parentheses. The line corresponds to p=0.05. (B) Representative photomicrographs of increasing magnification of cells in the placenta
undergoing apoptosis in situ in Het-U and Hom-P mutants on day 19 of pregnancy. Arrows indicate cells undergoing cell death (Tunnel: TMR red,
nuclei: DAPI). (C) Quantification of cells in the placenta undergoing apoptosis in situ for Het-U (n = 8) versus Hom-P (n = 8) on day 19 of pregnancy.
Scale bar = 200 mm, Tunnel: TMR red, nuclei: DAPI, Jz = Junctional zone, Lz = labyrinth zone. *p<0.05, unpaired t test. Data presented as individual
values with means ± SEM shown. (D) Transcription factors with binding sites enriched at the promoters of differentially expressed genes, as identified
by Analysis of Motif Enrichment (AME). (E) Regulatory network built with the four TFs identified by AME analysis using ingenuity pathway analysis. In
green are shown proteins that are down-regulated at mRNA level in Hom-P versus Het-P placentas, in blue are depicted TFs predicted as repressors
and in orange TFs predicted as activators.
DOI: https://doi.org/10.7554/eLife.45282.017
The following source data and figure supplements are available for figure 6:
Source data 1. List of differentially expressed genes obtained by RNA-seq comparing 5 Het-U and 4 Hom-P placentas on day 19 of pregnancy.
DOI: https://doi.org/10.7554/eLife.45282.021
Figure supplement 1. Sashimi plot showing RNA-seq reads for exons 18-20 of Pik3ca for the 4 Hom-P and 5 Het-U placentas analysed on day 19 of
pregnancy.
DOI: https://doi.org/10.7554/eLife.45282.018
Figure supplement 2. Validation of RNA-seq data.
DOI: https://doi.org/10.7554/eLife.45282.019
Figure supplement 3. Abundance of uterine natural killer cells in Hom-P versus Het-U placentas.
DOI: https://doi.org/10.7554/eLife.45282.020
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Terragni et al., 2011; Zhang et al., 2018) and/or implicated in the development of pregnancy com-
plications related to placental dysfunction (Than et al., 2018). Therefore, p110a operates via several
genes in the trophoblast to alter placental phenotype to support fetal growth.
PI3K p110a loss differentially affects the expression of genes in the
trophoblast and fetal cell lineages
We wanted to know whether the genes differentially expressed (DEGs) between Hom-P and Het-U
placentas, were expressed in the trophoblast or embryonic lineage of the conceptus. Using histol-
ogy, we assessed the expression of a few differentially expressed genes/proteins in the Hom-P and
Het-U placenta (Acta2/ACTA2, Cited2/CITED2, Lum/LUM). We found that these were localized to
both trophoblast (in junctional and labyrinthine zones) and epiblast-derived compartments (including
fetal vessels in the labyrinthine zone) in the placenta (Figure 7—figure supplement 1). However,
only the abundance of CITED2 protein followed a similar direction to the gene, in Hom-P compared
with Het-U placentas.
We also compared our RNA-seq dataset with existing trophoblast and embryonic stem cell (TS
and ES cell) transcriptomes using SeqMonk (Chrysanthou et al., 2018; Latos et al., 2015). We
found that 46 of DEGs were expressed in both cell types, and of these, 26 were highly enriched in
the TS compared to the ES cells (Figure 7—figure supplement 2).
Functional analysis revealed that the DEGs enriched in TS cells have been implicated in the con-
trol of extracellular exosome, whereas those enriched in ES cells are involved in regulating gene
expression and extracellular space (Figure 7—source data 1). These data suggested that p110a
may modulate different types of genes in the trophoblast and fetal cell lineages of the conceptus
and that some, but not all of the gene changes identified in our Hom-P versus Het-U analysis may be
a direct consequence of p110a loss in the trophoblast.
To explore these notions further, we deleted exons 18–19 of the Pik3ca gene using CRISPR/Cas9,
to diminish p110a protein expression in TS cells (Figure 7A–C). We then quantified the expression
of a subset of DEGs identified in vivo in the mutant p110a and wild-type TS cells (Figure 7D). These
experiments were additionally performed in ES cells to assess if loss of p110a would have a similar
effect on gene expression, as observed in mutant TS cells. Loss of p110a significantly reduced the
expression of B2m in mutant TS cells (Figure 7D), similar to findings in vivo from the Hom-P versus
Het-U placenta (Figure 6—source data 1). We also observed a trend for reduced expression of
Mzp12 upon TS p110a loss, although this did not reach statistical significance with the small number
of biological replicates used (p=0.079; Figure 7D). However, none of the other DEGs analyzed were
affected by TS p110a deficiency. These data suggest that the mis-regulated pattern of genes identi-
fied in the Hom-P versus Het-U placenta represent a combination of both direct and secondary
effects of trophoblast p110a loss.
Loss of p110a also had a more prominent impact on the expression of DEGs in ES cells. For
instance, p110a deficiency significantly increased the expression of Cited2, Pdlim3, Creb3l1, Mgst1,
Aldh1a3 in the ES cells (Figure 7D). For wildtype clones, the expression of the Pik3ca was overall,
more uniform in ES than TS cells (Figure 7B). Moreover, loss of p110a tended to increase the
expression of genes analyzed in ES cells, but decreased them in TS cells. Taken together, these data
demonstrate that pathways downstream of p110a differentially affect the expression of genes in the
trophoblast and fetal cell lineages of the conceptus.
Discussion
Here, using in vivo conditional genetic manipulations of p110a we have identified how the tropho-
blast and fetal cell lineages interact to control placental resource supply and thereby, affect healthy
growth of the fetus. The major cause of intrauterine growth restriction is placental insufficiency in
the developed world (Baschat and Hecher, 2004). Our results are therefore, important for under-
standing the etiology of placental insufficiency and intrauterine growth restriction.
The data presented here indicate that p110a in the fetal, but not the trophoblast compartment
of the conceptus determines placental size in late mouse pregnancy. The mechanism by which loss
of fetal p110a reduces formation of the placenta is unknown. Elongation of the fetal capillary net-
work is required for growth of the placenta, particularly its labyrinthine zone (Adamson et al., 2002;
Coan et al., 2004). Reduced fetal capillary formation in the labyrinthine zone of the Het-F could
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Figure 7. PI3K p110a differentially affects the expression of genes in the trophoblast and fetal cell lineages. (A) Details of CRISPR/Cas9 design to
delete exons 18–19 of Pik3ca in trophoblast or embryonic stem cells (TSC and ESC, respectively). The deletion in TSC (trophoblast stem cells) and ESC
(embryonic stem cells) was confirmed by (B) qRT-PCR analysis of exons 18–19 of Pik3ca and (C) by Western blotting for p110a. (D) The expression of
candidate genes in Pi3kca wildtype (WT) and mutant (Mut) TSC (n = 5 and n = 4, respectively) and ESC (n = 4 and n = 3, respectively). Data in (D) are
normalized against housekeeping Sdha. *p<0.05, ****p<0.0001, two-ways ANOVA analysis followed by Fisher post hoc test. Data presented as
means ± SEM.
DOI: https://doi.org/10.7554/eLife.45282.022
Figure 7 continued on next page
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therefore underlie the reduced placental weight and labyrinthine zone observed and data are consis-
tent with previous work showing defective angiogenesis and vascular development in the fetus and
placenta in response to p110a loss (Graupera et al., 2008; Sferruzzi-Perri et al., 2016). The reduc-
tion in fetal and placental weight was similar for Het-F conceptuses (both reduced by ~11%), sug-
gesting that perhaps the placenta grew to match the genetically-determined growth requirements
of the fetus (Sandovici et al., 2012). However, it is also plausible that placental growth decreased to
match the experimentally induced slower growth of the Het-F fetuses. Herein, the direct effects of
fetal p110a cannot be isolated from the indirect effects on the fetal growth restriction in Het-F on
day 19 of pregnancy. Thus, future work should assess the ontogeny of changes in placental pheno-
type with respect to the growth of the fetus in the Het-F during gestation.
The lack of an effect of trophoblast p110a deficiency in Het-P and Hom-P on placental weight
was surprising as both loss of IGF2 and protein kinase B (AKT), which are main up- and down-stream
mediators of PI3K signaling respectively cause placental growth restriction (Constância et al., 2002;
Kent et al., 2012; Plaks et al., 2011; Yang et al., 2003). Moreover, studies using non-isoform spe-
cific inhibitors have shown that Class 1A PI3Ks mediate the proliferative and survival effects of
ligands on trophoblast in vitro (Diaz et al., 2007; Forbes et al., 2008). Deleting p110a using the
conditional Pik3ca line in the current study does not alter the stoichiometry of PI3K complexes
(Graupera et al., 2008), and thus it is unlikely that other PI3K isoforms compensate for the loss of
p110a in the trophoblast. In the current study however, the expression of cell death genes were
down-regulated and the level of apoptosis in the Hom-P compared with Het-U placenta paradoxi-
cally upregulated on day 19 of pregnancy (~1 day prior to term). Differences between gene expres-
sion and tissue levels of apoptosis in our study may be relate to the low volume density (~20%) of
the junctional zone in the whole placenta which was used in the RNA analysis. Assessing the ontog-
eny of changes in cell death genes and the activation of apoptosis in the Hom-P placenta is required.
Moreover, whether placental weight (as well as morphology) may be decreased in Hom-P versus
Het-U in the last 24 hours prior to delivery remains to be determined.
Our stereological analyses of the Het-F, Het-P and Het-U placentas demonstrated that epiblast-
derived and trophoblast p110a have non-overlapping contributions in regulating the development
of the placental exchange region. In particular, p110a in the epiblast-derived compartment deter-
mined the size of the placental labyrinthine zone and its trophoblast constituent, whereas p110a in
the trophoblast was important for expanding the surface area for maternal-fetal exchange. More-
over, p110a in both the trophoblast and epiblast-derived lineages contributed to the formation of
the capillary network and the thinness of the diffusion barrier in the placental exchange region.
These findings are consistent with previous work demonstrating that the PI3K pathway regulates tro-
phoblast differentiation (Kent et al., 2010; Lee et al., 2019) and defects in p110a signaling impair
developmental angiogenesis and placental exchange region morphogenesis (Graupera et al., 2008;
Lelievre et al., 2005; Sferruzzi-Perri et al., 2016). However, we did not find expression of any
markers of known differentiated trophoblast subtypes (eg Syna, Synb, Gcm1, Ctsq), endothelial cells
(eg Pecam1) or angiogenesis (eg Ang1/2, Tie2, Vegf) in placentas that lacked p110a (in the Hom-P
compared to Het-U placenta by RNA-seq) thatwould explain the morphological phenotype
observed. As fetal capillary volume was affected by a deficiency of p110a signaling in the tropho-
blast and trophoblast volume was altered by a deficiency in fetal p110a, our data suggest that there
Figure 7 continued
The following source data and figure supplements are available for figure 7:
Source data 1. Functional predictions for the candidate genes enriched in trophoblast and embryonic stem cells cells (TSC and ESC, respectively).
DOI: https://doi.org/10.7554/eLife.45282.025
Source data 2. Primer sequence for RT-qPCR, PCR screening and CRISPR gRNAs target.
DOI: https://doi.org/10.7554/eLife.45282.026
Figure supplement 1. Localisation and abundance of CITED2, ACTA2 and LUM identified to be dysregulated at the gene level, in Hom-P versus Het-U
placentas on day 19 of pregnancy.
DOI: https://doi.org/10.7554/eLife.45282.023
Figure supplement 2. Expression profiles of the genes identified as dysregulated in Hom-P versus Het-U placentas in trophoblast stem cells (TS cells)
and embryonic stem cells (ES cells), as determined by analysis of existing RNA-seq datasets (Chrysanthou et al., 2018; Latos et al., 2015).
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is a paracrine communication between cellular compartments in the placental labyrinthine zone,
which occurs via p110a signaling. Paracrine signaling via p110a may also explain why when compar-
ing the three heterozygote lines, the Het-P placenta uniquely showed less maternal blood spaces
and a greater trophoblast volume. Paracrine communication between trophoblast and endothelial
cell lineages in the labyrinthine zone has been reported previously for other signaling proteins
(Limbourg et al., 2005; Lu et al., 2013; Moreau et al., 2014; Tang et al., 2006). Future work
should evaluate the density of different trophoblast cell types in the labyrinthine zone (eg. syncytial
trophoblast layer 1, syncytial trophoblast layer two and sinusoidal giant cells) in the Het-P and other
p110a mutant placentas.
Our analysis of placental transfer function in vivo revealed that independent of specific changes in
placental labyrinthine morphology with fetal versus trophoblast p110a loss, fetal glucose and System
A-mediated amino acid supply relative to the size of the fetus, was maintained or even increased
due to an adapting placenta which increased materno-fetal substrate clearance per unit surface
area. We found that in conceptuses with p110a deficiency, this adaptive up-regulation of placental
amino acid transport depended on the expression of p110a in the trophoblast; System A-mediated
amino acid transport was significantly lower for the Hom-P compared to the adapted Het-U pla-
centa. This inability of the Hom-P placenta to up-regulate System A amino acid transport, may
explain, at least partly, the further reduction in fetal weight, when compared to Het-U. Indeed, inhib-
iting System A-mediated amino acid transport during rat pregnancy in vivo leads to fetal growth
restriction (Cramer et al., 2002) and reductions in System A transporter activity occur prior to the
onset of intrauterine growth restriction in rats and baboons (Jansson et al., 2006; Pantham et al.,
2016). Previous work has shown that constitutive heterozygous loss of p110a activity in the concep-
tus (a/+mutants) does not affect the expression of glucose (Slc2a) or the sodium coupled System A
amino acid transporter (Slc38a) genes in the placenta (Sferruzzi-Perri et al., 2016). We also did not
find differential expression of these transporters in Hom-P compared to Het-U placenta by RNA-seq.
In other cell types, p110a alters the activity of glucose and sodium transporters on the plasma mem-
brane (Frevert and Kahn, 1997; Katagiri et al., 1996; Wang et al., 2008). Loss of p110a may
therefore, alter glucose and amino acid transport to the fetus by the placenta via post-transcriptional
mechanisms. Previous work has shown that when placental supply and fetal demand for resources to
grow are mis-matched, IGF2 in the fetus may directly or indirectly signal demand to the placenta to
adaptively up-regulate its transport of glucose and amino acids (Angiolini et al., 2011;
Constância et al., 2005; Sferruzzi-Perri et al., 2017; Sferruzzi-Perri et al., 2011). Our data there-
fore imply that demand signals of the compromised feto-placental unit, such as IGF2, operate via
p110a in the trophoblast to adapt amino acid supply to the fetus for growth. However, it is equally
possible that fetal demand signals operate via pathway/s independent of p110a. Moreover, it is
plausible that these pathway/s may be sufficient to compensate for the effects of moderately down-
regulated p110a in the Het-P, but are insufficient when p110a is markedly knocked-down as in the
Hom-P. Further work is required to identify the elusive fetal demand/s signals and explore the contri-
bution of other signaling pathways implicated in environmental sensing, in driving alterations in pla-
cental transport phenotype in response to p110a deficiency, including the mechanistic target of
rapamycin (mTOR), mitogen-activated pathway (MAPK), general control nonrepressed 2 (GCN2),
glucokinase, G-protein coupled-receptors (GPCRs) and adenosine monophosphate-activated protein
kinase (AMPK) (Efeyan et al., 2015).
Our transcriptomic comparison of the Hom-P and Het-U placentas identified several genes down-
stream of p110a that may be important in adapting placental phenotype to support fetal growth. Of
note, we found six granzyme encoding genes, were down-regulated in Hom-P compared with Het-
U. Others have shown that the PI3K pathway regulates granzyme expression and function of differ-
ent leukocyte populations (Blanco et al., 2015; Efimova and Kelley, 2009; Jiang et al., 2000), and
thus p110a could be playing a similar role in trophoblast. We also found that some of the genes dif-
ferentially expressed between Hom-P and Het-U placenta have been previously implicated in the
regulation of trophoblast differentiation (Cdx2) (Strumpf et al., 2005), growth and transport
(Cited2)(Withington et al., 2006) and hormonal regulation of maternal physiology (Prl5a1, Prl7c1,
Psg19 and Psg22) (Moore and Dveksler, 2014; Soares et al., 2007). Moreover, a number of genes
identified have been implicated in miscarriage (Fgl2) (Clark et al., 2001) and in the development of
placental dysfunction in the pregnancy complication, preeclampsia (Acta2, Ngf and Nov/Ccn3)
(Gellhaus et al., 2006; Sahay et al., 2015; Todros et al., 2007). We found significant enrichment of
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binding motifs for the transcription factors, STAT1, ARNT2, HMGA1 and MITF in the promoters of
genes differentially expressed between Hom-P and Het-U. Others have demonstrated that the PI3K
pathway modulates the activity of three of these transcription factors (Mounayar et al., 2015;
Sheu et al., 2017; Terragni et al., 2011; Zhang et al., 2018) and of note, there is an interaction
between p110a and STAT1 activity (Mounayar et al., 2015). Many of the differentially expressed
genes in Hom-P versus Het-U placenta, were found to be enriched in TS cells however, of the four-
teen candidates studied, only one was significantly altered in response to TS cell p110a deficiency.
Moreover, several of the genes/proteins differentially expressed in Hom-P versus Het-U placenta
(Cited2/CITED2, Acta2/ACTA2, Lum/LUM) were localized to both trophoblast in junctional and laby-
rinthine zones and fetal constituents including labyrinthine fetal vessels in the placenta. Thus, the
mis-regulated pattern of genes identified in the Hom-P versus Het-U placenta may be both a direct
consequence of p110a in the trophoblast, as well as the result of indirect effects on the embryonic
lineages (such as fetal capillaries) in the placenta, or in the decidua. Single-cell RNA-seq should be
performed on p110a mutant placentas in the future to substantiate this interpretation. Further work
is additionally required to assess more directly the contribution of genes differentially expressed
between Hom-P and Het-U placentas, in adaptive responses of the placenta (Sferruzzi-Perri et al.,
2011).
Loss of p110a in ES cells also affected the expression the candidate genes studied. However,
there were many more candidate genes significantly altered in the mutant ES cells and the pattern
of change was largely distinct to that observed for the mutant TS cells. Indeed, genes were typically
upregulated in ES cells, but reduced in TS cells in response to p110a deficiency. Moreover, the
genes differentially expressed between Hom-P and Het-U and enriched in TS and ES cells were pre-
dicted to participate in diverse cell functions, for example extracellular exosome and gene expres-
sion, respectively. These data imply that p110a regulates the expression of different genes and
functional pathways in the trophoblast and epiblast-derived tissues of the conceptus. They also rein-
force that the embryonic lineages of the conceptus are more sensitive to p110a loss than the tro-
phoblast and may provide some explanation for the lethality observed for the Hom-F but not Hom-P
mutants. These findings could be furthered in the future by performing RNA on TS and ES cells to
obtain a complete transcriptomic comparison in response to p110a deficiency. However, it is impor-
tant to note that TS and ES cells would not have been present in the wildtype or p110a mutant pla-
centas at the time of investigation (day 19 of pregnancy). Thus, extrapolating our findings of p110a
deficiency in ES and TS cells in vitro to our trophoblast or epiblast-derived manipulations in vivo, are
limited and should be taken cautiously.
Previous work has shown that the genotype and environment of the mother modulates placental
growth and transport function (Angiolini et al., 2011; Constância et al., 2005; Sferruzzi-
Perri et al., 2016; Sferruzzi-Perri et al., 2017; Sferruzzi-Perri et al., 2011). Moreover, litter compo-
sition and particularly, the presence of siblings of a different genotype in the litter can affect placen-
tal phenotype (Tunster et al., 2016). Indeed, in the current study, some of the values for the
placenta of the Het-F wildtype controls were higher than for the Het-U and Het-P (eg placental
weight, volume of labyrinthine zone trophoblast and fetal capillaries and surface area), which likely
reflects variations in the gestational environment (litter composition and maternal genotype/environ-
ment) for the individual groups. All data in the current study were obtained from litters of mixed
genotype and only comparisons to their respective control siblings were made to minimize possible
effects of variations in the gestational metabolic environment on placental phenotype. However, it is
important to note that changes in placental phenotype with fetal and trophoblast Pik3ca deletion
can still occur within the homogenous gestational environment and according to fetal genotype,
which was not assessed in the current study. Future work should, therefore, attempt to explore the
interactions between maternal p110a metabolic profile, litter composition and fetal genotype in the
regulation of placental resource allocation. This can, for instance, be done initially by measuring
maternal hormones and glucose/amino-acid levels in the diverse fetal/maternal genotype combina-
tions, but quantification of the ‘individual’ effects will be highly challenging.
Collectively, our data indicate that p110a plays distinct roles in the different compartments of the
conceptus, which ultimately affect placental phenotype and fetal growth. In particular, p110a in the
fetal lineages of the conceptus is essential for prenatal development and a major regulator of pla-
cental phenotype (Figure 8). Moreover, trophoblast p110a signaling is critical for its ability to up-
regulate amino acid transport to match fetal demands for growth near term. However, the Hom-F
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and Hom-P have a heterozygous deficiency of p110a in the trophoblast and epiblast-derived line-
ages, respectively. Thus, there may be interactions between the different compartments of the con-
ceptus that are heterozygous and homozygous deficient in p110a, which may have contributed to
the placental and fetal phenotypes observed for Hom-F and Hom-P. Furthermore, gene disruption
may occur up to 1.5 days earlier using the Meox2Cre, compared to the Cyp19Cre (at around days 5
and 6.5, respectively) (Tallquist and Soriano, 2000; Wenzel and Leone, 2007). Moreover, the
Cyp19Cre exhibits mosaic activity (observed herein and reported previously; Wenzel and Leone,
2007). Therefore, temporal differences in the timing of Cre activation and levels of Cre activity
between the Meox2Cre and Cyp19Cre lines may have contributed to feto-placental phenotypes
observed for the fetal versus trophoblast p110a mutants, in the current study. In addition, previous
characterization of Meox2Cre line has shown Cre is active in the yolk sac mesoderm (Tallquist and
Soriano, 2000). As the yolk sac is essential for fetal growth, loss of p110a from the yolk sac meso-
derm could have contributed to the fetal phenotypes observed with the Het-F and Hom-F. Employ-
ing alternative strategies to target expression of p110a in different conceptus lineages, such as
using lentiviral-mediated shRNA/siRNA transfection of mouse blastocysts (Georgiades et al., 2007;
Okada et al., 2007) are therefore, warranted in the future. Nevertheless our findings are important
in the context of human pregnancy, as dysregulated expression of both up and down-stream com-
ponents of the PI3K pathway in the placenta are associated with abnormal fetal growth and poor
pregnancy outcome (reviewed in Sferruzzi-Perri et al., 2017).
Figure 8. Summary figure showing the phenotypes of all p110a mutants used in this study, which together highlight that fetal and trophoblast p110a
have distinct contributions in regulating resource allocation to the growing fetus. Findings are from mice at day 19 of pregnancy, unless indicated
otherwise. AA=amino acid, BT=barrier thickness, FC=fetal capillaries, Lz=labyrinth zone, MBS=maternal blood spaces, SA=surface area for exchange.
DOI: https://doi.org/10.7554/eLife.45282.027
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Materials and methods
Mice and genotyping
Mice were housed under dark:light 12:12 conditions with free access to water and chow in the Uni-
versity of Cambridge Animal Facility abiding by the UK Home Office Animals (Scientific Procedures)
Act 1986 and local ethics committee. Home Office project license number is 70/7645. Mice in which
exons 18 and 19 of the p110a gene were flanked by LoxP sites (Pik3caFl) on a C57Bl6 background
were kindly provided by Dr Bart Vanhaesebroeck (University College London) and Dr Klaus Okken-
haug (Babraham Institute) (Graupera et al., 2008). These were time-mated with those expressing
the Cre recombinase gene under the control of the trophoblast-specific human Cyp19 promoter
(Wenzel and Leone, 2007), the embryonic Meox2 promoter (Tallquist and Soriano, 2000) or the
ubiquitous CMV promoter (Schwenk et al., 1995). This achieved three models that had a ~ 50%
decrease in p110a in the trophoblast, fetal lineages or whole conceptus, termed Het-P, Het-F and
Het-U, respectively. Further crosses were performed on a second generation of Het-U mice to selec-
tively delete the remaining p110a allele in the trophoblast using Cyp19Cre (Hom-P) or fetal lineage
using Meox2Cre (Hom-F). See Figure 1—source data 1 for experimental crosses used. Note the
wild-types for the Het-P and Het-U are the same animals and the Het-U were the controls for Hom-
P. The genotypes of the fetuses/mice were determined by PCR using primers to detect Cyp19Cre
(Fwd: GACCTTGCTGAGATTAGATC and Rev: AGAGAGAAGCATGTTTAGCTGG), Meox2Cre (Fwd:
GGACCACCTTCTTTTGGCTTC, Rev: AAGATGTGGAGAGTACGGGGTAG, Cre: CAGATCCTCC
TCAGAAATCAGC) and CMVCre (Cre Fwd: CGAGTGATGAGGTTCGCAAG, Cre Rev: TGAGTGAAC-
GAACCTGGTCG, Internal control Fwd: ATGTCTCCAATCCTTGAACACTG and Internal control Rev:
GCAGTGGGAGAAATCAGAACC). This was done using the following cycle conditions: 94˚C, 3 min,
then 35 cycles of 94˚C for 30 s, 57˚C for 30 s and 72˚C for 90 s, and then 72˚C for 7 min. Genotyping
was also performed by PCR using primers for Pik3caFl (Fwd:CTAAGCCCTTAAAGCCTTAC, Rev:
CAGCTCCCATCTCAGTTCA and Deletion: ACACACTGCATCAATGGC) as described previously
(Graupera et al., 2008) and by real time PCR (qRT-PCR) using Taqman probes (Pik3ca:
Mm00435672_g1 and Gapdh: Mm99999915_g1) to confirm deletion in whole fetal and placental tis-
sue homogenates. Due to the mosaic activity of the Cyp19Cre (Wenzel and Leone, 2007) a cut-off
for Pik3ca deletion in the placenta using qRT-PCR was set for <65% Het-P and <30% for Hom-P.
To visualize the Cre recombinase activity, Cyp19Cre and Meox2Cre mice were mated to the
Rosa26TdRFP reporter mouse line (Gt(ROSA)26Sor; purchased from the Jackson lab and a generous
gift from Prof William Colledge, University of Cambridge) (Soriano, 1999). Fetuses and placentas
were collected on day 16 of pregnancy, fixed in 4% (wt/vol) PFA, 30% (wt/vol) sucrose and then fro-
zen in OCT (optimal cutting temperature media, TissueTek) for cryosectioning and staining in DAPI.
Placental nutrient transfer assays
The unidirectional materno-fetal clearance of the non-metabolisable radioactive tracers, 14C-methyl
amino-isobutyric acid (MeAIB) and 3H-methyl D-Glucose (MeG) were measured under anesthesia
with fentanyl-fluanisone (hypnorm):midazolam (hypnovel) in sterile water (1:1:2, Jansen Animal
Health) (Sibley et al., 2004). A 200 ml bolus containing 3.5 mCi, of MeAIB (NEN NEC-671; specific
activity 1.86GBq/mmol, Perkin Elmer, USA) and 3.5 mCi MeG (NEN NEC-377; specific activity
2.1GBq/mmol) in physiological saline (0.9% wt/vol) was injected into the maternal jugular vein. Two
minutes after tracer injection, the dam was killed by cervical dislocation, uteri were collected and
fetal and placental weights recorded. Entire litters of placentas were collected for morphological
analyses or snap frozen in liquid nitrogen for quantification of gene expression. Fetuses were decapi-
tated, entire fetal tails taken for DNA genotyping and then fetuses minced and lysed at 55˚C in Bio-
sol (National Diagnostics, Atlanta, USA). Fetal lysates were measured for beta emissions by liquid
scintillation counting (Optiphase Hisafe II and Packard Tri-Carb, 1900; Perkin-Elmer USA) and radio-
activity (DPM; disintegrations per minute) in the fetuses was used to calculate transfer relative to the
estimated placental surface area or to fetal weight.
Placental morphological analyses
Placentas were bisected and one half was fixed in 4% (wt/vol) paraformaldehyde, paraffin-embed-
ding, exhaustively sectioned at 7 mm and stained with hematoxylin and eosin to analyse gross
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placental structure. The other half was fixed in 4% (wt/vol) glutaraldehyde, embedded in Spurr’s
epoxy resin and a single, and 1 mm midline section was cut and then stained with toluidine blue for
detailed analysis of labyrinthine zone (Lz) structure using the Computer Assisted Stereological Tool-
box (CAST v2.0) program as previously described (Coan et al., 2004). Briefly, to determine the vol-
ume densities of each Lz component (fetal capillaries [FC], maternal blood spaces [MBS] and
trophoblast), point counting was used and their densities were multiplied by the estimated volume
of the Lz to obtain estimated component volumes. Surface densities of maternal-facing and fetal-fac-
ing interhaemal membrane surfaces were then determined by counting the number of intersection
points along cycloid arcs in random fields of view. These were converted to absolute surface areas
and the total surface area for exchange calculated (averaged surface area of MBS and FC). The
mean interhaemal membrane thickness was determined by measuring the shortest distance between
FC and the closest MBS at random starting locations within the Lz. Per Lz, 200 measurements were
made. The harmonic mean thickness (barrier thickness) was calculated from the reciprocal of the
mean of the reciprocal distances.
Placental in situ cell death staining
Cells undergoing cell death were detected in paraffin-embedded sections of placenta using the In
Situ Cell Death Detection Kit, TMR red (Sigma Aldrich), according to the manufacturer’s instructions.
The proportion of TMR red to DAPI stained cells was determined in each placental section using
Image J (freeware software).
Placental immuno-localisation of protein abundance
For localization of p110a, placental sections were washed with PBS to remove OCT and underwent
antigen retrieval with citrate buffer before immunolabelling (antibody against p110a, Cell Signaling,
C73F8, 1:75 dilution). Sections were treated with 0.5% Triton X-100 before immunolabelling. Bound
antibody was detected using biotinylated goat anti-rabbit IgG (Abcam, ab6720) followed by strepta-
vidin-conjugated horseradish peroxidase (Rockland, S000-03) and 3,3-diaminobenzidine (DAB)
according to manufacturer instructions. Sections were lightly counterstained with hematoxylin and
mounted in DPX. Negative controls were performed by omission of the primary antibody. For
ACTA2 (R and D, MAB1420-SP, 5 mg/ml dilution), LUM (R and D, AF2745-SP, 5 mg/ml dilution),
CITED2 (R and D, AF5005-SP, 3 mg/ml dilution) and Dolichos Biflorus Agglutinin lectin (DBA; Vector;
B-1035; 6.6 mg/ml dilution) placental sections were de-paraffinized, rehydrated and subject to anti-
gen retrieval prior to immunolabelling. Bound antibody against DBA, CITED2, ACTA2 and LUM was
detected using biotinylated goat anti-rabbit (Abcam, ab6720), donkey anti-sheep (Abcam, ab97125),
horse anti-mouse (Vector, BA-2000) and horse anti-goat (Vector, BA-9500), respectively. This was fol-
lowed by incubation with streptavidin-conjugated horseradish peroxidase and visualization with DAB
staining, as described previously. Sections were lightly counterstained with nuclear fast red and
mounted in DPX. Analysis of each placental section was performed using Image J (freeware
software).
Placental RNA sequencing (RNA-seq)
Total RNA was extracted from whole placental halves using the RNeasy Plus Mini Kit (Qiagen, UK)
according to manufacturer’s instructions. RNA-seq libraries were prepared using TruSeq Stranded
total RNA library preparation kit (Illumina) and barcoded libraries were combined and submitted for
sequencing (50 bp single ended on a HiSeq2500) by the Wellcome Trust-MRC Institute of Metabolic
Science Genomics Core Facility. The number of raw reads per library was between 14.3 and 33.4 mil-
lion. Fastq files were aligned to mouse genome GRCm38 with TopHat (version 2.0.11; Kim 2013)
using default settings (The mapping percentage varied between 96.2% and 98.3%). Differential
expression was performed using Cuffdiff (version 2.1.1; Trapnell 2012) with the following settings;
require a minimum of 5 alignments to conduct significance testing, perform bias correction, do initial
estimation to weight multi-hits. Genes identified as differentially expressed (DEG) with Cuffdiff sig-
nificance indicated as q value < 0.05 and 1.5-linear fold expression change. Pathway analysis was
then determined using DAVID gene ontology (Huang et al., 2009) and redundant GO terms were
filtered-out using REViGO (Supek et al., 2011). The RNA-seq data have been deposited in NCBI’s
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Gene Expression Omnibus and are accessible through GEO Series accession number GSE126046
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126046).
To search for enrichment of transcription factor binding sites at the promoters of DEG, we used
Eukaryotic Promoter Database (EPD – https://epd.vital-it.ch/index.php) to retrieve the DNA sequen-
ces from 1,000 bp upstream to 100 bp downstream of the transcriptional start site. These sequences
were then analysed using Analysis of Motif Enrichment (AME v4.12.0 – http://meme-suite.org/tools/
ame) by selecting Mus musculus and HOCOMOCO Mouse (v11 FULL) as motif database. Transcrip-
tion factors predicted by AME and Ingenuity Pathway Analysis (IPA) were then used for network visu-
alization, performed using IPA.
CRISPR/Cas9 knockout in Trophoblast and Embryonic Stem Cells
For CRISPR/Cas9-mediated deletion of Pik3ca, E14tg2a embryonic stem cells (obtained from the
Mutant Mouse Regional Resource Center, UC Davis, USA) and TS-Rs26 trophoblast stem cells (a gift
of the Rossant lab, Toronto, Canada) (both cell lines were tested and negative for mycoplasma) were
transfected with Cas9.2A-eGFP plasmid (Plasmid 48138 Addgene) harboring guide RNAs flanking
the exon 18 and exon 19 (http://CRISPR.mit.edu) (Figure 7). Transfection was carried out with Lipo-
fectamine 2000 (ThermoFisher Scientific 11668019) reagent according to the manufacturer’s proto-
col. Knockout clones were confirmed by western blotting and by genotyping using primers spanning
the deleted exons, and by reverse transcription followed by semi-quantitative PCR (RT-qPCR) with
primers (AGGGAGCACAAGAGTACACCA and GGCATGCTGCCGAATTGCTA) within and down-
stream of the deleted exons, as shown in Figure 7. Values were normalized to Sdha expression.
Three to five independent knockout clones were analysed for each cell line. The expression of four-
teen genes found to be differentially regulated between Het-U and Hom-P placenta, were then
assessed by qPCR in p110a deficient TS and ES cells.
Gene expression by qRT-PCR
Total RNA was extracted from whole placental halves using the RNeasy Plus Mini Kit (Qiagen, UK)
whereas total RNA was extracted from TS and ES cells using trizol (Invitrogen), chloroform and etha-
nol extraction. Multiscribe Reverse Transcriptase and random primers (Applied Biosystems) were
used to synthesize cDNA from 2.5 ug of RNA. Samples were analysed in duplicate by qRT-PCR
(7500 Fast Real-Time PCR System, Applied Biosystems, UK) using Sybr green chemistry and pairs of
forward and reverse primers (Figure 7—source data 2). The expression of genes of interest were
normalized to the expression of Gapdh or Sdha which was not affected by genotype. Data were ana-
lysed using the 2–DDCT method for quantification.
Western blotting
Protein expression was quantified using p110a antibody (1:500; Cell Signaling, 4249), as described
previously (Sferruzzi-Perri et al., 2011).
Statistics
No explicit power analyses were used to predetermine sample size. Randomization was not used in
our studies. Analyses of placental morphology and in situ cell death staining were conducted blinded
to the genotype. The number of samples per group for each analysis is detailed in the legends of fig-
ures and footnotes of tables. Data are presented as mean ± SEM. Data were considered normally
distributed and analysed using unpaired and paired t tests with Excel, as required or two-way
ANOVA with GraphPad Prism 7. Data were considered statistically significant when p<0.05.
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Supek F, Bošnjak M, Škunca N, Šmuc T. 2011. REVIGO summarizes and visualizes long lists of gene ontology
terms. PLOS ONE 6:e21800. DOI: https://doi.org/10.1371/journal.pone.0021800, PMID: 21789182
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